Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).

Date publication

octobre 2020

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier , Dr DEBIEUVRE Didier , Dr MANSI Laura

Tous les auteurs :
Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard AC, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano AL, Zalcman G, Aparicio T,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33129039

Résumé

Cancer patients are thought to have an increased risk of developing severe Coronavirus Disease 2019 (COVID-19) infection and of dying from the disease. In this work, predictive factors for COVID-19 severity and mortality in cancer patients were investigated.

Mots clés

COVID-19, Cancer, Chemotherapy, Death, Immunotherapy, Intensive care unit, Mechanical ventilation, Mortality, Radiotherapy

Référence

Eur J Cancer. 2020 Oct 8;141:62-81